Menu

Therapeutic Areas

 

Woman with cancer and child - The challenges of immuno-oncology combined clinical development, Part IV

The challenges of immuno-oncology combined clinical development, Part IV

In the final of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.

Read more...
 

Cancer patient The challenges of immuno-oncology combined clinical development, Part III

The challenges of immuno-oncology clinical development, Part III

In the third of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.

Read more...
 

Cancer patient with medical professional for the challenges of combination therapies in immuno-oncology clinical development

The challenges of immuno-oncology clinical development, Part II

In the second of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.

Read more...
 

Challenges of immuno-oncology clinical development

The challenges of immuno-oncology clinical development, Part I

In the first of a four-part series, Jai Balkissoon, vice president of global product development, writes about the increase in immuno-oncology therapies.

Read more...
 

Honoring World Alzheimer’s Day Neuroscience Research

Honoring World Alzheimer's Day

Stephen Peroutka, vice president and therapeutic area head in neuroscience, shares his thoughts on the importance and outlook of conducting clinical trials for Alzheimer’s disease.

Read more...
Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.